• Product name

    Anti-WIPI1 antibody [EPR8110]
    See all WIPI1 primary antibodies
  • Description

    Rabbit monoclonal [EPR8110] to WIPI1
  • Host species

  • Tested applications

    Suitable for: WB, IHC-Pmore details
    Unsuitable for: Flow Cyt,ICC or IP
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide within Human WIPI1 aa 50-150. The exact sequence is proprietary.

  • Positive control

    • A375, BxPC3, 293T, C6, RAW264.7, NIH 3T3, and JAR cell lysates; Human colon tissue.
  • General notes



    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.



Our Abpromise guarantee covers the use of ab128901 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Detects a band of approximately 49 kDa (predicted molecular weight: 49 kDa).
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
  • Application notes
    Is unsuitable for Flow Cyt,ICC or IP.
  • Target

    • Function

      May play a role in autophagy. May regulate the trafficking of proteins involved in the mannose-6-phosphate receptor (MPR) recycling pathway.
    • Tissue specificity

      Ubiquitously expressed. Highly expressed in skeletal muscle, heart, testis, pancreas and placenta. Highly expressed in G361, Sk-mel-28, Sk-mel-13, WM852 and WM451 cells. Up-regulated in a variety of tumor tissues.
    • Sequence similarities

      Belongs to the WD repeat SVP1 family.
      Contains 3 WD repeats.
    • Cellular localization

      Golgi apparatus > trans-Golgi network. Endosome. Cytoplasmic vesicle > clathrin-coated vesicle. Trans elements of the Golgi and peripheral endosomes. Dynamically cycles through these compartments and is susceptible to conditions that modulate membrane flux. Enriched in clathrin-coated vesicles.
    • Information by UniProt
    • Database links

    • Alternative names

      • ATG 18 antibody
      • ATG18 antibody
      • Atg18 protein homolog antibody
      • ATG18A antibody
      • FLJ10055 antibody
      • WD repeat domain phosphoinositide interacting 1 antibody
      • WD repeat domain phosphoinositide interacting protein 1 antibody
      • WD repeat domain phosphoinositide-interacting protein 1 antibody
      • WD40 repeat protein interacting with phosphoinositides of 49 kDa antibody
      • WD40 repeat protein interacting with phosphoInositides of 49kDa antibody
      • WIPI 1 alpha antibody
      • WIPI 1 antibody
      • WIPI 49 antibody
      • WIPI 49 kDa antibody
      • WIPI-1 antibody
      • wipi1 antibody
      • WIPI1_HUMAN antibody
      • WIPI49 antibody
      see all


    • All lanes : Anti-WIPI1 antibody [EPR8110] (ab128901) at 1/1000 dilution

      Lane 1 : A375 cell lysate
      Lane 2 : BxPC3 cell lysate
      Lane 3 : 293T cell lysate
      Lane 4 : C6 cell lysate
      Lane 5 : RAW264.7 cell lysate
      Lane 6 : NIH 3T3 cell lysate
      Lane 7 : JAR cell lysate

      Lysates/proteins at 10 µg per lane.

      All lanes : Goat anti-Rabbit HRP at 1/2000 dilution

      Predicted band size: 49 kDa

    • ab128901 at 1/50 dilution staining WIPI1 in Paraffin-embedded Human colon tissue by Immunohistochemistry.

      Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

    • Equilibrium disassociation constant (KD)
      Learn more about KD

      Click here to learn more about KD


    This product has been referenced in:

    • Chen K  et al. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis 9:105 (2018). IF . Read more (PubMed: 29367621) »
    • Chen K  et al. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy. FASEB J N/A:fj201801749RRR (2018). Read more (PubMed: 30571313) »
    See all 3 Publications for this product

    Customer reviews and Q&As

    Immunohistochemistry (Frozen sections)
    Mouse Tissue sections (Brain)
    Yes - 0.3%
    Blocking step
    Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 37°C

    Abcam user community

    Verified customer

    Submitted Aug 24 2018

    For licensing inquiries, please contact partnerships@abcam.com

    Sign up